. Surrogate endpoints and FDA's accelerated approval process. Health Aff (Millwood). 2005 Jan-Feb;24(1):67-78. PubMed.

Recommends

Please login to recommend the paper.

Comments

Comments on this Paper

No Available Comments

Make a Comment

To make a comment you must login or register.

This paper appears in the following:

News

  1. Take It From the Agency: First FTD Drug May Be an Orphan